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ABSTRACT
In utero infection of the fetus has become recognized as an important cause of fetal and neonatal
morbidity and mortality. Since both anatomic and functional abnormalities have been described in
the fetus related to various infections, ultrasonography may be a valuable diagnostic tool in this
regard. A complete review of the current literature was undertaken to report available information
on this topic. Common pathogens or clinical conditions were selected. The identified data were
confounded by the way in which each case originally presented for study. Although certain anoma-
lies were frequently associated with individual organisms, their incidence could not be determined,
nor were most specific to that infectious agent. Representative ultrasound images are presented for
common and unusual cases. Infect. Dis. Obstet. Gynecol. 5:262-270, 1997. (C) 1997 Wiley-Liss, Inc.
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n utero infection of the fetus has become recog-
nized as an important cause of fetal and neonatal
morbidity and mortality. As our awareness of the
number of pathogenic organisms increases, so too
does our appreciation of the potential for in utero
diagnosis of these infections. Both anatomic and
functional abnormalities in the fetus have been de-
scribed for many types of infection. The focus of
this report is on the use of ultrasonography as a tool
to recognize, and monitor, these infectious compli-
cations. Although a great deal of recent literature
has become available concerning invasive means
(e.g., amniocentesis, cordocentesis) to diagnose in
utero infection, this is beyond the scope of the
current review.
Most of the data to be presented are derived
from limited sources, including case reports or
small case series. These sources are biased by the
way the case presents, i.e., if infection was recog-
nized prospectively, or if a given anomaly led to a
thorough workup of the patient which included po-
tential infectious agents. Therefore, associations
may be drawn, but absolute cause and effect rela-
tionships should be tempered by the quality of the
data. Similarly, an accurate incidence of a given
ultrasound-based anomaly is hard to establish due
to the rarity of most infectious processes.
VIRAL INFECTIONS
Cytomegalovirus (CMV)
CMV remains the most common congenital virus
infection, affecting an estimated 0.4-2.3% of all
liveborn infants. 1,e The virus itself is a double-
stranded DNA herpes virus with multiple strains
identified. An increased incidence of seropositivity
is encountered in lower socioeconomic strata with
variation between regions of the country. Diagnosis
of a primary maternal infection requires demonstra-
tion of the presence ofCMV-IgM antibodies in the
absence of CMV-IgG, as well as seroconversion of
CMV-specific IgG antibody from negative to posi-
tive. Presence of IgG antibodies without docu-
mented seroconversion is not helpful in diagnosing
the primary maternal infection thought responsible
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Fig. I.
edema.
Ultrasound manifestations of non-immune fetal hydrops: (a) hydrothorax, (b) ascites, () polyhydramnios, (d) scalp
for in utero infection. Approximately 2% of sero-
negative patients will convert during pregnancy. Of
these primary CMV infections, 40% result in fetal
infection. Only 10% of fetal infections result in sig-
nificant disease." It is in this group that ultrasound
findings consistent with fetal infection would be
expected. The role of prenatal diagnosis of fetal
infection is not clear in the absence of ultrasound
evidence of fetal disease. Isolation of CMV from
amniotic fluid was first reported in 1971,4 and
amniotic fluid viral culture remains the gold stan-
dard for diagnosis of fetal infection. The use of
fetal blood sampling for culture and detection of
CMV IgM is not as sensitive as amniocentesis,s
Non-specific serologic findings including anemia,
thrombocytopenia, elevated liver function tests,
and elevated total IgM levels support a diagnosis of
in utero infection but do not necessarily correlate
with severity of fetal disease.
Many of the manifestations ofCMV infection in
the neonate may be detected prenatally and war-
rant further evaluation. The ultrasound findings as-
sociated with CMV are non-specific and include
hepatosplenomegaly (74%), microcephaly (50%),
intrauterine growth retardation (IUGR) (41%), and
cerebral calcifications.6 The presence of fetal as-
cites and/or non-immune hydrops (Fig. 1) is more
frequently noted with severe infections. The intra-
cranial calcifications may be accompanied by ven-
triculomegaly (Fig. 2) or intrahepatic calcifications,
however, mild ventriculomegaly may be an isolated
finding. Subtle signs include oligo- or polyhydram-
nios. Less common ultrasound findings described
include pulmonary hypoplasia, isolated pericardial
or pleural effusions, and echogenic bowel (Fig.
3). 7,8 Discordant effects have been described in
multiple gestations.9,1
As with all fetal infections, the ultrasound diag-
nosis of abnormalities indicates a more severe dis-
ease and worse prognosis. The findings associated
with CMV are not unique to this infection, how-
ever, the relative frequency of CMV infection
makes it more commonly encountered. Any patient
with ultrasound findings of in utero infection war-
rants inclusion of CMV in the differential.
Rubella
Rubella (German measles) is a well-characterized,
mild exanthematous disease of childhood caused
by a single-stranded RNA virus of the togavirus
INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY 263IN UTERO INFECTION PUDER ET AL.
Fig. 2. Ventricular dilatation with scattered calcifications
(arrow), consistent with CMV infection.
Fig. 4. Large septated desquamating skin lesion (arrow) of
right upper extremity in congenital HSV infection.
Fig. 3. Echogenic bowel; note loops of small intestine out-
lined by calcifications.
family. In the pregnant host, this disease can have
catastrophic effects on the fetus, as first described
by Gregg in 1941.11 The last epidemic in the pre-
vaccine era (1964-1965) resulted in approximately
11,000 miscarriages, abortions, and stillbirths, and
approximately 20,000 cases of congenital rubella
syndrome in the newborn, le Since the introduction
of an effective vaccine in 1969, the incidence of
clinical infection has dramatically declined, al-
though there has been a recent resurgence of ru-
bella identified by the Centers for Disease Control
and Prevention (CDC). 1"
Based on reported neonatal clinical characteris-
tics of the disease, ultrasound-identified manifes-
tations of in utero infection could include cardiovas-
cular defects (pulmonary artery hypoplasia, coarc-
tation of the aorta), microphthalmos, microcephaly,
polycystic kidney, IUGR, and hepatosplenomeg-
aly. A less likely identifiable abnormality, yet rela-
tively common finding in the infected newborn, is
congenital cataracts. Other typical features of con-
genital rubella infection, including hearing loss,
purpura, and mental retardation, cannot be identi-
fied by ultrasound imaging. It is interesting to note
that due to the difference in time frames between
the peak occurrence of this congenital infectious
disease and the availability of ultrasonography, no
reported ultrasound-based cases have ever been
published in the literature.
Herpes Simplex Virus (HSV)
Congenital HSV infection is often severe, with a
high morbidity and mortality. Most cases are ac-
quired during delivery through an infected birth
canal. Intrauterine infection may also occur, either
through transplacental passage of virus or ascend-
ing local infection. Transplacental infection may
result in a neonate born with skin lesions, multi-
system organ failure, and central nervous system
(CNS) lesions consistent with destruction of devel-
oping brain tissue (microcephaly, microphthalmia,
chorioretinitis, hydranencephaly, multicystic en-
cephalomalacia). Several cases of prenatally de-
tected lesions of congenital HSV infection have
been reported. Reports of destructive intracranial
lesions include hydranencephaly diagnosed on a 30
week ultrasound 14 and ventriculomegaly, enlarged
cisterna magna, and 4th ventricle cyst on a 30 week
ultrasound, in the presence of a normal 22 week
study. Non-immune hydrops, with skin edema,
pleural effusion, and ascites, has also been reported
as a manifestation of this congenital infection.6 A
recent report detected large desquamating skin le-
sions (Fig. 4), restricted fetal movement, lymph-
adenopathy (Fig. 5), and intrahepatic calcifications
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Fig. 5. Multiple echogenic masses adjacent to the cervical
spine (arrow), consistent with cervical lymphadenopathy.
(Fig. 6) on an ultrasound performed at 19 weeks. 17
The correct diagnosis was confirmed with invasivc
testing and supported by studies after termination
of the pregnancy. The destructive CNS lesions
tend to be more severe than those seen with other
infections. The bullous skin lesions appear unique
to HSV.
Human Immunodeficiency Virus (HIV)
Infection with HIV leads to a chronic, progressive
illness culminating in the acquired immunodefi-
ciency syndrome (AIDS) and death. The shifting
epidemiology of this infectious agent is highlighted
by the fact that women of reproductive age are now
one of the most rapidly growing populations with
HIV infection. In pregnancy, evidence of maternal
to fetal transmission is well documented. This can
occur early in gestation or during the labor and
delivery process. Marion et al. s,19 were the first to
describe a dysmorphic syndrome in children ex-
posed to HIV in utero. Features of this cmbryopa-
thy included growth failure (75%), microcephaly
(70%), and craniofacial abnormalities consisting of
ocular hypertelorism (50%), prominent forehead
(75%), fiat nasal bridge (70%), obliquity of the eyes
(65%), long palpebral fissures (60%), short nose
(65%), and patulous lips (60%). The authors pos-
tulated that the variable expression of these HIV-
associated physical findings may relate to the tim-
ing of exposure in pregnancy. It is now believed
that the above findings are not specific to HIV, but
are secondary to confounding factors, such as eth-
nicity, poor nutrition, substance abuse, and con-
comitant infections. Ades ctal.,e from the Euro-
pean Collaborative Study, did not detect case of
Fig. 6. Coronal view of the fetal thorax and abdomen;
note the large areas of calcification within the fetal liver
(arrow).
HIV dysmorphic syndrome in more than 600 cases
studied. To date, no ultrasound-based data exist
describing the in utero identification of the HIV-
infected fetus.
Varicella-Zoster Virus (VZV)
Maternal VZV infection had been identified to re-
sult in transplacental infection of the fetus. The
clinical spectrum of disease varies from asymptom-
atic seroconversion in the neonate to severe forms
of symptomatic congenital VZV syndrome. This
latter condition has been identified in utero by ul-
trasonography and can be categorized into two
types: a virus-specific deformation sequence and a
non-specific, non-immune hydrops-like picture.
The deformation sequence consists of some com-
bination of the following ultrasound findings: limb
hypoplasia, cicatricial skin lesions, microphthal-
mos, and abnormal positioning of extremities. Fo-
cal intracranial calcifications, club feet, polyhy-
dramnios, hydrocephalus, liver echogenicities, and
arthrogryposis, although not specific for VZV infec-
tion, have also been reported,z Balducci et al.,ee
however, prospectively examined pregnant women
with VZV infection throughout gestation and noted
that in utero ultrasound detection of structural ab-
normalities associated with VZV infection was rare.
In their study, 36 women with first trimester chick-
enpox were examined with ultrasonography at 16-
20 weeks of gestation with no abnormalities iden-
tified in any of the fetuses. Scattered case reports
do present convincing evidence for in utero infec-
tion. For example, Scharf et al.z- documented ma-
ternal rash, positive neonatal virologic studies for
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Fig. 7. Pericardial effusion shown in both real time and M-mode ultrasound.
VZV and antenatal ultrasound findings of massive
hydramnios, bilateral hydrocephalus, bilateral real-
positioning of hands and feet, and skin edema in
one case.
These findings are tempered by others noting
that these lesions develop over time and fetuses at
risk should be followed serially. Several authors
have cautioned that too early an examination of the
fetus may miss evidence of fetal infection. Prcto-
rius et al. zl performed serial ultrasound examina-
tions in VZV-infccted gravidas and noted a latency
period of at least 5 weeks before ultrasound find-
ings of infection were detected. Similarly, Harding
and Baumcrz4 reported on a case of maternal vari-
cella infection at 14 weeks gestation with a normal
ultrasound examination at 17 weeks, and a severely
compromised neonate with contracturcs and pos-
rural deformities involving all extremities at deliv-
ery. Additionally, a report of maternal varicella at
11 weeks gestation, with serial ultrasonography ev-
ery 4 weeks, did not reveal abnormalities until 22
weeks, when atrophy of the muscles of the left leg
and malposition of the left foot were noted,z-
The second type of in utero presentation, non-
immune hydrops, also appears long after the initial
maternal VZV infection has subsided. Three gravi-
das with varicella infection before 20 weeks of ges-
tation were noted to have ultrasound features in
the fetus consistent with viral infection only in the
third trimester,z6-zs These findings included hepa-
tomcgaly, ascitcs, pleural effusion, pcricardial effu-
sion, and liver calcifications.
Parvovirus
Parvovirus B19 may infect both children and
adults, and generally has a benign course in these
patients. Significant disease in the fetus may be
caused by in utcro infection. Sonographic signs of
fetal infection have been reported from 3 to 12
weeks after maternal infection,z9 Numerous case
reports have documented a broad range of antena-
tal ultrasound findings in infected fetuses.3-4
When abnormalities are detected during antenatal
ultrasound, they are almost exclusively abnormal
fluid collections and are believed to be due to fetal
anemia and/or myocarditis. Therefore, placental
thickening, polyhydramnios, pleural and pericar-
dial effusions (Fig. 7), ascites, skin edema, and car-
diomegaly are the most frequently found manifes-
tations.
Others cases may present as a fetal demise,35
twin gestation with clinical findings of twin-twin
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transfusion syndrome,
36 or oligohydramnios. 37
Congenital anomalies have rarely been associated
with documented parvovirus infection. Although
anomalies are suggested by a report of a fetus di-
agnosed at 13 weeks (cystic hygroma and no mid-
line intracranial echo) with progression at 16 weeks
(no midline intracranial echo, thick nuchal fold, fe-
tal hands and feet in abnormally flexed position,
growth at less than the 5th percentile), these may
be coincidental. Despite a normal karyotype, the
pregnancy was terminated and parvovirus was
found in multiple tissues, though none was found
in maternal blood.3s A recent report of two cases of
hydrocephalus in association with this fetal infec-
tion, after normal second trimester ultrasound ex-
aminations,4 does raise the possibility that congen-
ital anomalies may bc in the spectrum of disease.
The in utero natural history of this disease pro-
cess, in particular the ultrasound-related findings,
is poorly defined. This is due to the relative rarity
of this condition, the variable gcstational age at
diagnosis, and the now common attempt at ther-
apeutic intervention (e.g., in utero transfusion).
However, serial ultrasound studies of even severely
affected fetuses have shown resolution of the hy-
dropic changes.
33 Humphrey and colleagues
39 re-
ported on a 26 week fetus with parvovirus infection
and hydrops, anhydramnios, thickened placenta,
bilateral pleural effusions, cardiomcgaly, pericar-
dial effusion, and marked ascitcs. With observa-




The incidence of syphilis in the general U.S. popu-
lation has increased significantly over the past few
years, with a current rate of approximately 14-15
cases per 100,000 persons.4 Although the exact in-
cidence in pregnancy is undetermined, a 4-fold in-
crease in congenital syphilis cases has recently
been reported.4e Unfortunately, congenital syphilis
is first suspected in many cases when the ultra-
sound report demonstrates a fetal demise,4 consis-
tent with the 22% incidence of fetal demise in
mothers with syphilis reported in the 1930s.4e
These features of fetal demise have been well de-
scribed elsewhere.44 Fetal infection can be diag-
nosed in utero, and may be the cause of ultraso.no-
graphic findings of non-immune hydrops. Classi-
Fig. 8. Isolated placental thickening (>4 cm) in a 26 week
gestation consistent with in utero syphilis infection.
cally, the feature of placental thickening (Fig. 8) is
reported in the literature as consistent with this in
utero infection. Additional findings may include as-
cites and skin edema.4s,46 Although the data are
limited, Nathan et al.47 reported the incidence of
ultrasound-detected hepatomcgaly to be 57%, pla-
cental thickening 62%, and ascites 17% in infected
fetuses. Ultrasound detection of dilatation of fetal
bowel has been reported and is associated with fi-
brotic and infiltrative processes causing obstruc-
tion.4s,49 The characteristic bone findings of con-
genital syphilis have also been detected in utero,s
Both abnormal bone morphometry (three standard
deviations below normal for gcstational age) and
morphology (thickening, curvature, and multiple
areas of bowing) were described. Despite the nu-
merous other potential observable ultrasound fea-
tures of congenital syphilis, none has been reported
in the recent literature. Data are lacking with
regard to the effect of aggressive antimicrobial
therapy and the resolution of syphilis-related ultra-
sonographic abnormalities.
Intraamniotic Infection (Chorioamnionitis)
As previously mentioned, in addition to anatomic
abnormalities, ultrasound-based functional aberra-
tions in the fetus have bccn reported which arc
associated with infection. Vintzileos and col-
leaguess were the first to introduce the concept of
using biophysical profile testing to detect occult
fetal infection. In their study of 73 gravidas with
premature rupture of the membranes, a low bio-
physical score (-<7) was a good predictor of im-
pending fetal infection. When subdivided into in-
dividual components, the first manifestations of
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impending infection were loss of fetal breathing
and non-reactive non-stress testing. Conversely,
the presence of fetal breathing had the highest
specificity in predicting absence of fetal infection.
In this series, testing was done on a daily basis, and
it appears that this frequency is necessary to pro-
vide accurate fetal assessment related to infection.
Use of biophysical profile testing for subclinical
infection remains controversial. Miller et al.se were
not able to identify a relationship between any
component of the biophysical profile and subse-
quent clinical chorioamnionitis. This study was
limited by the absence of any identified neonatal
sepsis in the study group. This has prompted the
suggestion that biophysical profile testing may be
more accurate in its ability to detect impending
subclinical fetal infection as opposed to maternal
infection. The rationalization for this latter per-
spective is that the loss of reactivity, movement,
breathing, and tone in the fetus is similar to these
same non-specific signs seen with newborn sepsis
in the nursery. In a recent study by Carroll et al.,s
study subjects with premature rupture of the mem-
branes underwent ultrasound testing, cordocente-
sis, and amniotic fluid sampling in an attempt to
identify in utero infection. Although there was a
tendency for lower biophysical profile scores and
amniotic fluid indices, the majority of subjects with




Antenatal infection with Toxop/asma gondii is seen
frequently in Europe and may cause significant se-
quelae. The initial infection leads to focal tissue
necrosis and destruction, most often in the brain,
heart, lungs, and liver. Classic manifestations of se-
vere disease include choriorctinitis, convulsions,
hydrocephalus, and intracranial calcifications. Of
these, the latter two may be diagnosed by antenatal
ultrasound.
Abnormalities of the cerebral ventricles (Fig. 9),
ranging from mild ventriculomegaly to severe hy-
drocephalus,s4 and in rare instances to hydranen-
cephaly,ss are the most frequent prenatal ultra-
sound findings in this infection. The dilatation of
the ventricles is usually symmetricals and may de-
velop weeks after the prenatal diagnosis has been
madc.S7-s9
Fig. 9. Periventricular calcifications.
Intracranial calcifications without distinct pat-
tern may be seen in utero,s Characteristic intra-
cranial findings and their progression have also
been noted in utero, with documented fetal toxo-
plasmosis infection. Mild ventriculomegaly and
periventricular hyperechoic areas of -<2 mm were
first detected at 30 weeks of gestation and repeat
ultrasound at 33 weeks revealed progressive hydro-
cephalus, increase in the size (10 mm) and number
of hyperechoic areas, and polyhydramnios. Non-
specific findings of infection have also been docu-
mented: ascites, hepatomegaly, increased placental
thickness, calcifications in the fetal liver, pericar-
dial and pleural effusions, oligohydramnios, and in-
trauterine growth restriction,s<61-6 Though the
presence of ultrasound findings may prompt inves-
tigation, it should be noted that the majority (ap-
proximately 80%) of prenatally diagnosed cases of
congenital toxoplasmosis do not have detectable
ultrasound abnormalities,s4,s9,l’4
CONCLUSIONS
Although some infections acquired in utero have
classic ultrasound findings, there is a significant
overlap between infectious agents. Non-immune
hydrops, intrauterine growth restriction, ventricu-
lomegaly, and fluid abnormalities form a significant
component of the ultrasound findings in these in-
fections. Therefore, in the absence of more specific
features, any patient warranting evaluation for
these findings would benefit from the inclusion of
infectious etiologies in the diagnostic process.
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